KATHLEEN SMERKO: Open Payments
NPI 1366453029 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$496 in 18 payments from 7 companies in 2025. Trend: 2023 $46 · 2024 $113 · 2025 $496
Food & beverage: $496
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 7 | $235 |
| Gilead Sciences, Inc. | 4 | $97 |
| Merck Sharp & Dohme LLC | 3 | $69 |
| GlaxoSmithKline, LLC. | 1 | $35 |
| ABBVIE INC. | 1 | $23 |
| Napo Pharmaceuticals Inc | 1 | $19 |
| Organon LLC | 1 | $18 |
Products named: CABENUVA, PIFELTRO, APRETUDE, Yeztugo, MAVYRET, Mytesi, NEXPLANON.
Industry payments across AZ — which companies pay providers there.
